Serum extracellular vesicle-derived miRNA-105-5p can be transferred to ESCC cells and contribute to ESCC proliferation through targeting SPARCL1 and regulating the FAK/Akt signaling pathway. The gene discussed is SPARCL1; the disease is esophageal squamous cell carcinoma.